CAS: 12271-95-3; ——
该化合物是无机化合物,由于结构中存在银和,具有独特的特性;该化合物一般是固体,通常以晶状形式出现;氧化银因其电导和热稳定性等各个领域的潜在用途而闻名,包括电子和材料科学;可通过各种方法合成,包括涉及氧化银和氧化物的固态反应;该化合物可能具有有趣的光学特性,成为光学应用研究的课题;此外,在不同环境条件下,其稳定性是一个重要的特征,影响其实际应用的可用性;与许多银化合物一样,它也可能表现出抗微生物特性,在某些应用中可能是有益的;然而,由于与银化合物有关的潜在毒性,应当采取预防措施.
MSDS等安全信息
欧盟法规
ECHA物质ECHA物质C&L通报REACH预注册合成工艺路线路线简述
专利信息
专利号:WO-2021038419-A1
优先权日:2019-08-23
标题 :Kinase inhibitors and methods of synthesis and treatment
发明人：ZAVORONKOVS ALEKSANDRS; IVANENKOV YAN; POLYKOVSKIY DANIIL; ALIPER ALEKSANDR
权利人:INSILICO MEDICINE IP LTD
摘要:Compounds that function as kinase inhibitors are provided. The kinase inhibitors can have any structure of the formulae provided herein, such as shown for Compounds 1-4. A pharmaceutical composition can include: the compound of one of the embodiments; and a pharmaceutically acceptable carrier having the compound. A method of inhibiting a kinase can include: providing the compound of one of the embodiments described herein to the kinase such that the kinase is inhibited. The methods can include inhibiting DDR1 and/or DDR2, and thereby providing a modulation or decrease in the activity of DDR1 and/or DDR2. This decrease in DDR1 and/or DDR2 activity can be used as therapy to treat conditions related to DDR1 and/or DDR2 activity, such as fibrosis, cancer, and others.
